OTCPK:PHMZ.F

Stock Analysis Report

Executive Summary

Protech Home Medical Corp. provides and rents in-home monitoring equipment and services for patients in the United States.

Snowflake

Fundamentals

Reasonable growth potential with adequate balance sheet.

Risks

  • Protech Home Medical is covered by less than 3 analysts.

Share Price & News

How has Protech Home Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

16.1%

PHMZ.F

0.008%

US Healthcare

-0.2%

US Market


1 Year Return

23.8%

PHMZ.F

-9.0%

US Healthcare

1.1%

US Market

PHMZ.F outperformed the Healthcare industry which returned -9.4% over the past year.

PHMZ.F outperformed the Market in United States of America which returned 1.6% over the past year.


Share holder returns

PHMZ.FIndustryMarket
7 Day16.1%0.008%-0.2%
30 Day3.9%-0.8%2.5%
90 Day13.1%-1.5%1.6%
1 Year23.8%23.8%-7.6%-9.0%3.4%1.1%
3 Yearn/a29.6%24.4%45.2%35.8%
5 Yearn/a66.2%56.2%62.6%44.8%

Price Volatility Vs. Market

How volatile is Protech Home Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Protech Home Medical undervalued based on future cash flows and its price relative to the stock market?

4.54x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Protech Home Medical's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Protech Home Medical's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Protech Home Medical is loss making, we can't compare its value to the US Healthcare industry average.

Protech Home Medical is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Protech Home Medical, we can't assess if its growth is good value.


Price Based on Value of Assets

Protech Home Medical is overvalued based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is Protech Home Medical expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

167.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Protech Home Medical's revenue is expected to grow by 14.8% yearly, however this is not considered high growth (20% yearly).

Protech Home Medical's earnings are expected to grow significantly at over 20% yearly.

Protech Home Medical's revenue growth is expected to exceed the United States of America market average.

Protech Home Medical's earnings growth is expected to exceed the United States of America market average.

Protech Home Medical's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Protech Home Medical will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Protech Home Medical performed over the past 5 years?

-10.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Protech Home Medical does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Protech Home Medical's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Protech Home Medical's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Protech Home Medical has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Protech Home Medical has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Protech Home Medical improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Protech Home Medical's financial position?


Financial Position Analysis

Protech Home Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Protech Home Medical's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Protech Home Medical's level of debt (86.2%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has increased over the past 5 years (7.3% vs 86.2% today).


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 2x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Whilst loss making Protech Home Medical has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.

Whilst loss making Protech Home Medical has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -96.6% per year.


Next Steps

Dividend

What is Protech Home Medical's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Protech Home Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Protech Home Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Protech Home Medical has not reported any payouts.

Unable to verify if Protech Home Medical's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Protech Home Medical has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Protech Home Medical's salary, the management and board of directors tenure and is there insider trading?

2.8yrs

Average management tenure


CEO

Greg Crawford 0

1.8yrs

Tenure

CA$1,286,117

Compensation

Mr. Gregory J. Crawford also known as Greg, has been Chief Executive Officer President and Director of Protech Home Medical Corp. (also known as Patient Home Monitoring Corp.) ("PHM") since December 21, 20 ...


CEO Compensation Analysis

Greg's remuneration is higher than average for companies of similar size in United States of America.

Greg's compensation has increased whilst company is loss making.


Management Age and Tenure

2.8yrs

Average Tenure

49yo

Average Age

The tenure for the Protech Home Medical management team is about average.


Board Age and Tenure

3.8yrs

Average Tenure

The tenure for the Protech Home Medical board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyCA$99,89702 Nov 18
D. Ewing
EntityIndividual
Role
Member of the Board of Directors
Non-Executive Director
Shares218,333.2
Max PriceCA$0.46
BuyCA$510,16302 Nov 18
Gregory Crawford
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares1,115,000
Max PriceCA$0.46
BuyCA$228,77302 Nov 18
Hardik Mehta
EntityIndividual
Role
Chief Financial Officer
Chief Financial Officer
Shares500,000
Max PriceCA$0.46
BuyCA$39,86403 Oct 18
D. Ewing
EntityIndividual
Role
Member of the Board of Directors
Non-Executive Director
Shares60,000
Max PriceCA$0.68
BuyCA$268,22025 Sep 18
Gregory Crawford
EntityIndividual
Role
Chief Executive Officer
Chairman
Shares505,000
Max PriceCA$0.54

Ownership Breakdown


Management Team

  • Thomas Roehrig (53yo)

    Executive Vice President of Finance

    • Tenure: 0yrs
  • Robbie Grossman (45yo)

    Corporate Secretary

    • Tenure: 0yrs
  • Leslie Becker

    Executive Vice President of Business Development

    • Tenure: 8.3yrs
  • W. Zehnder (44yo)

    Chief Strategy Officer & Investor Relations

    • Tenure: 0yrs
    • Compensation: CA$308.24k
  • Greg Crawford

    Chairman

    • Tenure: 1.8yrs
    • Compensation: CA$1.29m
  • William Frazier (61yo)

    Chief Medical Officer

    • Tenure: 3.9yrs
  • Hardik Mehta

    Chief Financial Officer

    • Tenure: 1.6yrs
    • Compensation: CA$1.15m
  • Jerry Kirn

    Vice President of Operations

    • Tenure: 0yrs
  • Mark Miles

    Vice President of Technology

    • Tenure: 0yrs

Board Members

  • Mark Greenberg

    Director

    • Tenure: 1.8yrs
    • Compensation: CA$695.98k
  • Gene Ewing (70yo)

    Non-Executive Director

    • Tenure: 1.1yrs
    • Compensation: CA$115.33k
  • Steven Axelrod

    Member of the Board of Advisors

    • Tenure: 5.9yrs
  • Jim Booth

    Member of the Board of Advisors

    • Tenure: 5.9yrs
  • Greg Crawford

    Chairman

    • Tenure: 1.8yrs
    • Compensation: CA$1.29m

Company Information

Protech Home Medical Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Protech Home Medical Corp.
  • Ticker: PHMZ.F
  • Exchange: OTCPK
  • Founded: 1993
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$71.000m
  • Listing Market Cap: CA$53.569m
  • Shares outstanding: 83.53m
  • Website: https://www.protechhomemedical.com

Location

  • Protech Home Medical Corp.
  • 1019 Town Drive
  • Wilder
  • Kentucky
  • 41076
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PTQTSXV (TSX Venture Exchange)YesNew Common SharesCACADDec 2017
1P4DB (Deutsche Boerse AG)YesNew Common SharesDEEURDec 2017
PHMZ.FOTCPK (Pink Sheets LLC)YesNew Common SharesUSUSDDec 2017

Biography

Protech Home Medical Corp. provides and rents in-home monitoring equipment and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; INR self-testing e ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 01:34
End of Day Share Price2019/09/19 00:00
Earnings2019/06/30
Annual Earnings2018/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.